Active surveillance for patients with prostate cancer aged ≥75 years: the Prostate Cancer Research International: Active Surveillance ( PRIAS) ‐ JAPAN study

British Journal of Urology 2026 Open access

Read full text
Authors: Takuma Kato, Akira Yokomizo, Ryuji Matsumoto, Hiroshi Fukuhara, Yoichiro Tohi, Keiichiro Mori, Masaki Shiota, Toru Kanno, Yoichi Robertus Fujii, Shinichi Sakamoto, Kazuhiro Suzuki, Yasuo Kojimoto
+8 more Masashi Nakayama, Takayuki Goto, Y. Matsuoka, K. Hashine, Yukio Naya, Yasuyuki Sakai, Takuma Sato, Mikio Sugimoto
DOI: 10.1111/bju.70156
Cited by: 1
References: 30

Abstract

OBJECTIVES: To investigate clinical outcomes, treatment, and survival rates of men aged ≥75 years with prostate cancer in Japan. PATIENTS AND METHODS: The study used data from the Prostate Cancer Research International: Active Surveillance (PRIAS)-JAPAN, a nationwide, multicentre prospective cohort study of men with clinically localised prostate cancer managed with active surveillance (AS). The original eligibility criteria were clinical stage T1c-T2 disease, prostate-specific antigen (PSA) level ≤10 ng/mL, PSA density (PSAD)

Fields of Study & Subjects

Prostate Cancer Diagnosis and Treatment Prostate Cancer Treatment and Research Health Promotion and Cardiovascular Prevention

Publication details

Journal / source
British Journal of Urology
Publisher
Wiley
Volume
137
Issue
4
Pages
650–658
Publication date
29 January 2026
Language
EN